Jill Libles Feldman, Byoung Chul Cho, Weimin Li, Nicolas Girard, Milena Perez Mak, Maxwell Sauder, Farastuk Bozorgmehr, Jiunn-Liang Tan, Jin-Yuan Shih, Danny Nguyen, Enriqueta Felip, Julia Schuchard, Tonatiuh Romero, Karen Xia, Joshua Michael Bauml, Jairo Simoes, Parthiv Jasvant Mahadevia, Mark A. Wildgust, Alexander I. Spira. "Dermatologic prophylaxis and impact on patient-reported outcomes in first-line
            <i>EGFR</i>
            -mutant advanced NSCLC treated with amivantamab plus lazertinib: Results from the phase 2 COCOON trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8641